India Pharma Outlook Team | Thursday, 06 November 2025
Cupid Ltd., a health and wellness products leading manufacturer, revealed that it foresees producing annual revenue of Rs 115 crore from the South African market, after its achievement of securing the largest allocation under the national procurement programme for contraceptive products of the country.
The five-year procurement programme (2025–2030) is about the supply of both male and female condoms, which makes Cupid the company leading South Africa’s public health and prevention initiatives.
The firm announced that the procurement rollout will be done from December 2025 and Cupid will be in close coordination with approved South African distributors for them to have a seamless and efficient phased implementation.
The entire money visibility under the scheme is around $12.98 million (Rs 115 crore) per year, the company stated.
Also Read: WHO and Bayer Extend Pact to Tackle Neglected Diseases
On this occasion, Aditya Kumar Halwasiya, Chairman and Managing Director of Cupid Ltd, by the way, said, "These allocations put Cupid in the center of the South African prevention program. We are working closely with customers and public health systems to ensure a smooth start in December 2025 and steady supplies thereafter."
He also mentioned that the arrangement would notably enhance the international order pipeline of Cupid, thus, the company will be able to go beyond its previous annual guidance and this is what is making the company very confident about the capacity expansion which is still underway.
This event is a significant step towards the worldwide expansion plan of Cupid and, at the same time, it confirms the company’s leadership in the sexual health and wellness product segment.